In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1839 News Items found
Q&A
Pictured: Ming Li
Study Suggests New Ways of Manipulating Immune System to Treat Autoimmune Diseases and Cancer

Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.
Announcement
Pictured: Michel Sadelain & Jedd Wolchok
Memorial Sloan Kettering Researchers Appointed to Stand Up To Cancer Immunology “Dream Team”

Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.
Q&A
Pictured: Lorenz Studer
Developmental Biologist Lorenz Studer Comments on the 2012 Nobel Prize in Physiology or Medicine

Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients.
Announcement
Pictured: Charles Sawyers
President Obama Names Physician-Scientist Charles Sawyers to National Cancer Advisory Board

Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer.
Announcement
Pictured: 2012 Rock Stars of Science
Geoffrey Beene Rock Stars of Science™ Campaign Features Memorial Sloan Kettering Researchers

The initiative, focused on investigators from Memorial Sloan Kettering’s Geoffrey Beene Cancer Research Center, highlights the critical need for funding scientific research.
Q&A
Pictured: Scott Lowe
At Work: Biologist Scott Lowe, Chair of the Geoffrey Beene Cancer Research Center

In the lab of cancer biologist Scott Lowe, researchers are investigating the processes that naturally inhibit cancer development.
In the Lab
Pictured: PET Scan
New Imaging Agent Could Improve Prostate Cancer Diagnosis and Treatment

Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.
Equipped for Discovery

Various facilities provide the services and technology that support Memorial Sloan Kettering’s cancer genomics studies.
Event
Hundreds of high school students and teachers from the New York City area attend the annual seminar.
Webcast of 2012 Major Trends in Modern Cancer Research

For the first time, our annual seminar for high school students and teachers from the New York City area will be available to watch live from around the nation and the world.
Q&A
Pictured: Ping Chi
At Work: Physician-Scientist Ping Chi

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.